REDUCED SEROLOGICAL RESPONSE TO COVID-19 BOOSTER VACCINES IN PATIENTS WITH IBD IS FURTHER DIMINISHED BY TNF INHIBITOR THERAPY; VARIATION STUDY PART 2 (VARIABILITY INRESPONSEIN IBDAGAINSTSARS-COV-2IMMUNISATION)
Jayne Doherty 1
Neil O´Morain 2
Roisin Stack 2
Miriam Tosetto 2
Rosanna Inzitari 3
Elizabeth Ryan 4
David J. Daghfal 5
Peter Doran 5
Colm O'Morain 6
Glen A Doherty 6
1 St Vincent's Hospital, Dublin, Ireland
2 St. Vincent's University Hospital, Dublin, Ireland
3 University College Dublin, Dublin, Ireland
4 University Limerick, Limerick, Ireland
5 Abbott Laboratories, Lake Forest, IL, United States
6 Trinity College Dublin - Faculty of Health Sciences, Trinity College Dublin, Dublin/IE, Dublin
Topic
IBD, Neurogastroenterology & Motility, Nurses, Primary Care
Conference
UEG Week Vienna 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]